tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

OptimizeRx sees FY25 adjusted EBITDA at least $12M

The Company is providing full year 2025 guidance and expects revenue to be at least $100 million with an Adjusted EBITDA of at least $12 million.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1